The US Food and Drug Administration (FDA) cleared Biora Therapeutics’s investig...
Orchard Therapeutics will receive several expedited drug development benefi...
Want to stay on top of the science and politics driving biotech today? Sign up t...
Join STAT for a discussion with two VCs as they weigh in on what distinguishes g...
Pfizer is stopping development of a twice-daily oral obesity medication after an...
Black children with drug-resistant epilepsy were less likely than white patients...
Pfizer said Friday it was stopping development of a twice-daily oral obesity med...
House Republicans want to use a small cut to hospitals’ Medicare payments to hel...
PEPFAR has been a lifeline in Ukraine. Now, two people who work for SAFEMed in U...
After weeks of anticipation, the U.S. Supreme Court on Monday will hear argument...
Some radiologists worry that patients will end up more anxious than they were be...
“Adult congenital patients are not an emerging heart failure subgroup, but one t...
The Texas attorney general has filed a lawsuit accusing Pfizer of “unlawfully” a...
House Republicans struggled to pin the new CDC director down on what they see as...
This week on the "The Readout LOUD" podcast: Are ADCs having a moment? Is CAR-T ...
This year’s meeting of the Radiological Society of North America surfaced the te...